Dear Molecular Imaging Insider,
June has seen a cornucopia of scientific and medical research presented in nuclear medicine. In addition, a host of new products and business ventures have launched in the molecular imaging marketplace, from new SPECT/CT systems to educational initiatives.
June also witnessed the end of a long struggle to achieve reimbursement for PET imaging for Alzheimer's disease from the U.S. Centers for Medicare and Medicaid Services (CMS). More importantly, the favorable decision may open the door to PET reimbursement for additional dementia and oncologic indications.
Cardiac PET has also been gaining attention the past few months. Our feature story for this newsletter reviews a study examining 2D and 3D cardiac PET image reconstruction using filtered back projection (FBP) and attenuation-weighted ordered-subsets expectation maximization (AW-OSEM) algorithms.
The researchers conducted a head-to-head comparison of the techniques to determine the quantitative accuracy of each protocol. As a Molecular Imaging Insider subscriber, you have access to this story before it’s published for the rest of our AuntMinnie.com members. To read more about image reconstruction with 2D and 3D cardiac PET, click here.
If you haven't yet had a chance, be sure to take a look at our coverage of this month's Society of Nuclear Medicine annual meeting. There were several breakthroughs announced at the Philadelphia meeting on both clinical and business issues.
